Burning mouth syndrome and mast cell activation disorder

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology

Volumn 111, Issue 4, 2011, Pages 465-472

  Afrin, Lawrence B ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; STEM CELL FACTOR;

ARTICLE; BIOSYNTHESIS; BURNING MOUTH SYNDROME; CASE REPORT; FEMALE; GENETICS; HUMAN; MAST CELL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SYSTEMIC MASTOCYTOSIS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BURNING MOUTH SYNDROME; FEMALE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H2 ANTAGONISTS; HUMANS; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; STEM CELL FACTOR;

EID: 79952905920     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tripleo.2010.11.030     Document Type: Article

References (46)

1. N.L. Rhodus, C.R. Carlson, and C.S. Miller Burning mouth (syndrome) disorder Quintessence Int 34 2003 587 593 (Pubitemid 37176105)
2. J.A. Ship, M. Grushka, J.A. Lipton, A.E. Mott, B.J. Sessle, and R.A. Dionne Burning mouth syndrome: an update J Am Dent Assoc 126 1995 842 853
3. M. Bergdahl, and J. Bergdahl Burning mouth syndrome: prevalence and associated factors J Oral Pathol Med 28 1999 350 354 (Pubitemid 29413876)
4. A. Scala, L. Checchi, M. Montevecchi, and I. Marini Update on burning mouth syndrome: overview and patient management Crit Rev Oral Biol Med 14 2003 275 291 (Pubitemid 44560797)
5. L.L. Patton, M.A. Siegel, R. Benoliel, and A. De Laat Management of burning mouth syndrome: systematic review and management recommendations Oral Surg Oral Med Oral Pathol Oral Radiol Endod 103 Suppl 1 2007 e1S39.e13
6. A. Tefferi, and A. Pardanani Clinical, genetic, and therapeutic insights into systemic mast cell disease Curr Opin Hematol 11 2004 58 64 (Pubitemid 38021722)
7. H. Ibelgaufts "Mast Cells" in COPE: Cytokines and Cells Online Pathfinder Encyclopaedia Revision June 14, 2010 http://www.copewithcytokines.de/ cope.cgi?key=mast%20cells November 23, 2010
8. L.J. Roberts, L.B. Anthony, and J.A. Oates Disorders of vasodilator hormones: carcinoid syndrome and mastocytosis J.D. Wilson, D.W. Foster, H.M. Kronenberg, P.R. Larsen, Williams Textbook of Endocrinology 9th ed. 1998 Saunders Philadelphia 1718 1732
9. G. Pejler, E. Rnnberg, I. Waern, and S. Wernersson Mast cell proteases: multifaceted regulators of inflammatory disease Blood 115 2010 4981 4990
10. T.C. Theoharides, D. Kempuraj, M. Tagen, P. Conti, and D. Kalogeromitros Differential release of mast cell mediators and the pathogenesis of inflammation Immunol Rev 217 2007 65 78 (Pubitemid 46718152)
11. H.P. Horny, D.D. Metcalfe, J.M. Bennett, B.J. Bain, C. Akin, L. Escribano, and P. Valent Mastocytosis S.H. Swerdlow, E. Campo, N.L. Harris, WHO classification of tumors of hematopoietic and lymphoid tissues 4th ed. 2008 International Agency for Research on Cancer Lyon 54 63
12. C. Akin, and D.D. Metcalfe The biology of Kit in disease and the application of pharmacogenetics J Allergy Clin Immunol 114 2004 13 19 (Pubitemid 39005112)
13. C. Akin, P. Valent, and D.D. Metcalfe Mast cell activation syndrome: proposed diagnostic criteria J Allergy Clin Immunol 2010 10.1016/j.jaci.2010.08. 035 e-pub ahead of print
14. P. Valent, C. Akin, L. Escribano, M. Fdinger, K. Hartmann, and K. Brockow Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria Eur J Clin Invest 37 2007 435 453 (Pubitemid 46817344)
15. G.J. Molderings, U.W. Kolck, C. Scheurlen, M. Brss, J. Homann, and I. Von Kgelgen Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder Scand J Gastroenterol 42 2007 1045 1053 (Pubitemid 47301141)
16. G.J. Molderings, K. Meis, U.W. Kolck, J. Homann, and T. Frieling Comparative analysis of mutation of tyrosine kinase Kit in mast cells from patients with systemic mast cell activation syndrome and healthy subjects Immunogenetics 62 2010 721 727
17. S. Fedele, G. Fricchione, S.R. Porter, and M.D. Mignogna Burning mouth syndrome (stomatodynia) Qual J Med 100 2007 527 530 (Pubitemid 47241919)
18. J.M. Zakrzewska The burning mouth syndrome remains an enigma Pain 62 1995 253 257
19. M. Grushka, J.B. Epstein, and M. Gorsky Burning mouth syndrome Am Fam Physician 65 2002 615 621
20. F. Bogetto, G. Maina, G. Ferro, M. Carbone, and S. Gandolfo Psychiatric comorbidity in patients with burning mouth syndrome Psychosom Med 60 1998 378 385 (Pubitemid 28279986)
21. E. Eliav, B. Kamran, R. Schaham, R. Czerninski, R.H. Gracely, and R. Benoliel Evidence of chorda tympani dysfunction in patients with burning mouth syndrome J Am Dent Assoc 138 2007 628 633
22. J.M. Zakrzewska, H. Forssell, and A.-M. Glenny Interventions for the treatment of burning mouth syndrome Cochrane Database Syst Rev 1 2005 CD002779
23. R.M. Cibirka, S.K. Nelson, and C.A. Lefebvre Burning mouth syndrome: a review of etiologies J Prosthet Dent 78 1997 93 97
24. P. Valent Mast cells, masters, and mastocytosis: development of research since the times of Paul Ehrlich Wien Klin Wochenschr 116 2004 645 646 (Pubitemid 39518121)
25. B.L. Gruber Mast cells in the pathogenesis of fibrosis Curr Rheum Rep 5 2003 147 153
26. J. Longley, T.P. Duffy, and S. Kohn The mast cell and mast cell disease J Am Acad Dermatol 32 1995 545 561 [erratum: J Am Acad Dermatol 1995;33:523]
27. J.L. Rosbotham, N.M. Malik, P. Syrris, S. Jeffery, A. Bedlow, and S. Gharraie Lack of c-Kit mutation in familial urticaria pigmentosa Br J Dermatol 140 1999 849 852 (Pubitemid 29238456)
28. L. Golkar, and J.D. Bernhard Mastocytosis Lancet 349 1997 1379 1385 (Pubitemid 27197549)
29. J. Homann, U.W. Kolck, A. Ehnes, T. Frieling, M. Raithel, and G.J. Molderings Systemic mastocytosis: state of an internal disease Med Klinik 105 2010 544 553 German
30. L.B. Afrin Mast cell activation disorder masquerading as pure red cell aplasia Int J Hematol 91 2010 907 908
31. N. Banner, M. Farzan, and D.S. Friend Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro J Virol 75 2001 10808 10814 (Pubitemid 33031550)
32. L.B. Schwartz, A.M.A. Irani, K. Roller, M.C. Castells, and N.M. Schechter Quantitation of histamine, tryptase and chymase in dispersed human T and TC mast cells J Immunol 138 1987 2611 2615 (Pubitemid 17051840)
33. L.B. Schwartz Analysis of MC(T) and MC(TC) mast cells in tissue Methods Mol Biol 315 2006 53 62
34. 2 in patients with systemic mastocytosis N Engl J Med 303 1980 1400 1404 (Pubitemid 11197529)
35. L.B. Schwartz, R.A. Lewis, and K.F. Austen Tryptase from human pulmonary mast cells: purification and characterization J Biol Chem 256 1981 11939 11943
36. P. Prasad, A.A. Yanagihara, A.L. Small-Howard, H. Turner, and A.J. Stokes Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A J Immunol 181 2008 5024 5034
37. J.G. Freeman, J.J. Ryan, C.P. Shelburne, D.P. Bailey, L.A. Bouton, and N. Narasimhachari Catecholamines in murine bone marrow derived mast cells J Neuroimmunol 119 2001 231 238 (Pubitemid 32918331)
38. L.-G. Kindblom Factor VIIIrelated antigen and mast cells Acta Pathol Microbiol Scand 90A 1982 1 6 437-9
39. L. Escribano, B. Diaz-Agustin, and A. Lpez Immunophenotypic analysis of mast cells in mastocytosis: when and how to do it Proposals of the Spanish Network on Mastocytosis (REMA) Cytometry B Clin Cytom 58B 2004 1 8 (Pubitemid 38332714)
40. R.D. Brunning, J.L. Parkin, R.W. McKenna, R. Risdall, and J. Rosai Systemic mastocytosis: extracutaneous manifestations Am J Surg Pathol 7 1983 425 438
41. M. Swieter, T.D. Lee, R.H. Stead, H. Fujimaki, and D. Befus Mast cell pleomorphism: properties of intestinal mast cells Advances Exper. Med Biol 216A 1987 613 623
42. K. Wager-Smith, and A. Markou Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition? Neurosci Biobehav Rev 35 2011 742 764
43. W.C. Blonski, E.E. Furth, B.P. Kinosian, C. Compher, and D.C. Metz A case of Cronkhite-Canada syndrome with taste disturbance as a leading complaint Digestion 71 2005 201 205 (Pubitemid 41160946)
44. V. Ho, L. Banney, and H. Falhammar Hyperpigmentation, nail dystrophy, and alopecia with generalised intestinal polyposis: Cronkhite-Canada syndrome Australas J Dermatol 49 2008 223 225
45. E. Ward, H.C. Wolfsen, and C. Ng Medical management of Cronkhite-Canada syndrome South Med J 95 2002 272 274 (Pubitemid 34136448)
46. H.P. Hahn, and J.L. Hornick Immunoreactivity for CD25 in gastrointestinal mucosal mast cells is specific for systemic mastocytosis Am J Surg Pathol 31 2007 1669 1676 (Pubitemid 350287564)